A Prospective Randomized Study of Posterolateral Lumbar Fusion Using Osteogenic Protein-1 (OP-1) Versus Local Autograft With Ceramic Bone Substitute
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Spine
- Vol. 31 (10) , 1067-1074
- https://doi.org/10.1097/01.brs.0000216444.01888.21
Abstract
A prospective, randomized and controlled study. To evaluate the osteoinductive property of Osteogenic Protein-1 (OP-1 or BMP-7) and fusion rate in human instrumented posterolateral lumbar fusion through radiographic examination, surgical exploration, and histologic assessment. The use of osteoinductive agents is a current topic in spinal fusion. Numerous preclinical investigations have demonstrated efficacy of osteoinductive proteins in spinal fusion, but few human clinical studies have been reported. Nineteen patients with L3–L4 or L4–L5 degenerative spondylolisthesis underwent posterolateral lumbar fusion using pedicle screw instrumentation. The patients were randomized to receive either OP-1 Putty (3.5 mg OP-1/g of collagen matrix per side) alone (n = 9), or local autograft with HA-TCP granules (n = 10). Fusion status was evaluated using plain radiography and CT scan. Radiographic fusion criteria included less than 5° of angular motion, less than 2 mm of translation, and evidence of bridging bone in the posterolateral lumbar area in which the graft materials were placed following decortication. After a minimum 1-year follow-up, the patients who showed radiographic evidence of fusion underwent instrumentation removal and surgical exploration of the fusion site. Biopsy specimens were taken from the fusion mass and evaluated histologically. Radiographic fusion rate was 7 of 9 OP-1 patients and 9 of 10 control patients. Based on surgical exploration of these 16 patients, new bone formation was macroscopically observed in the posterolateral lumbar region in all cases; however, solid fusion was observed in 4 of 7OP-1 and 7 of 9 HA-TCP/autograft patients. Histologic assessment demonstrated viable bone in 6 of 7 OP-1 patients. All the control (HA-TCP/autograft) specimens contained viable bone and fibrous tissue surrounding ceramic granules, suggesting slow incorporation of the graft material. In a human posterolateral lumbar spine trial, OP-1 reliably induced viable amounts of new bone formation, but the fusion success rate evaluated by surgical exploration was only 4 of 7.Keywords
This publication has 33 references indexed in Scilit:
- Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in HumansSpine, 2002
- Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Noninstrumented Posterolateral Lumbar FusionSpine, 2002
- ?-tricalcium phosphate as a bone substitute for dorsal spinal fusion in adolescent idiopathic scoliosis: preliminary results of a prospective clinical studyEuropean Spine Journal, 2001
- Does Spinal Instrumentation Influence the Healing Process of Posterolateral Spinal Fusion?Spine, 1999
- 1997 Volvo Award Winner in Clinical StudiesSpine, 1997
- The Use of an Osteoinductive Growth Factor for Lumbar Spinal FusionSpine, 1995
- The Role of Fusion and Instrumentation in the Treatment of Degenerative Spondylolisthesis with Spinal StenosisJournal of Spinal Disorders, 1993
- Pseudarthrosis of the SpineClinical Orthopaedics and Related Research, 1992
- Roentgenographic and biomechanical analysis of lumbar fusions: A canine modelJournal of Orthopaedic Research, 1989
- Bone: Formation by AutoinductionScience, 1965